What does Oramed Pharmaceuticals Inc. do?

Oramed Pharmaceuticals Inc. (ORMP.TA) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is ORMP.TA's market cap?

Oramed Pharmaceuticals Inc. (ORMP.TA) has a market capitalization of approximately $65.60 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does ORMP.TA pay a dividend?

Yes — Oramed Pharmaceuticals Inc. (ORMP.TA) pays a dividend special, with a trailing-twelve-month yield of 4.90%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

ORMP.TA

Oramed Pharmaceuticals Inc.

TLV·Biotechnology · Healthcare

ILA 1,603.00ILA 151.00+10.40%

Market capILA 65.60B·Market closed·Aug 26 12:38 PM UTC

Price Chart

ILA 1,603.00+ILA 151.00 (+10.40%)today

−72.58%CAGR −22.81%

Select date range

FromTo

Jul 13, 2017Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)4.90%

Annual Dividend (FWD)ILA 78.58

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio601.7%

FCF Payout Ratio—

Most Recent DividendILA 78.58

Ex-Dividend DateJan 16

Payment DateJan 26

EarningsEarnings Tab

EPS (FWD)$2.31

P/E Ratio (FWD)693.10

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateNov 12

Last Report DateAug 10

Reported vs EstimateILA 5.67 vs ILA 1.28

Earnings Surprise+343.0%

FinancialsFinancials Tab

Revenue$0.00

Net Income$174.51M

Net Margin—

Operating Cash Flow−$5.46M

Capital Expenditures$2.14M

Free Cash Flow−$7.60M

Return on Equity55.4%

Return on Invested Capital−0.6%

Net Cash$49.50M

Analyst Estimates

PRO

Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.

Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for ORMP.TA and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how ORMP.TA's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ORMP.TA and 80,000+ other tickers.

About Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.

CEO: Nadav Kidron
Sector: Healthcare
Industry: Biotechnology
Exchange: TLV
Employees: 13
Website: www.oramed.com

Peers

Latest News

News Tab

No recent news available.

Frequently Asked Questions About ORMP.TA

What does Oramed Pharmaceuticals Inc. do?: Oramed Pharmaceuticals Inc. (ORMP.TA) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is ORMP.TA's market cap?: Oramed Pharmaceuticals Inc. (ORMP.TA) has a market capitalization of approximately $65.60 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does ORMP.TA pay a dividend?: Yes — Oramed Pharmaceuticals Inc. (ORMP.TA) pays a dividend special, with a trailing-twelve-month yield of 4.90%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.